Dental implant supplier BioHorizons hopes to raise up to $100 million in an initial public offering (IPO) of its common stock and has filed a registration statement with the U.S. Securities and Exchange Commission.
BioHorizons intends to apply to list the shares on the Nasdaq Global Market under the symbol BHZN.
The company plans to use the proceeds to repay debt and expand its U.S. and international distribution channels.
Last year the company was the sixth-largest dental implant company based on sales in North America, according to iData Research.
Copyright © 2010 DrBicuspid.com
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.RbyOLNR6ps.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
